Prevalence of Major Depressive Disorder in Parkinson’s Disease at Srinagarind Hospital
Keywords: Parkinson’s disease, depression, prevalence
AbstractObjective : To study the prevalence of major depressive disorder (MDD) and factors associated with MDD among patients with Parkinson’s disease in Srinagarind hospital
Method : A descriptive cross-sectional study was conducted. One hundred and thirty nine patients with Parkinson’s disease at neurology clinic (OPD) were recruited during December
2012 to November 2013. The measurements were structured interview questionnaires consisting of 3 parts: 1) demographic data 2) history of Parkinson’s disease and factor associated with depression in Parkinson’s disease 3) questionnaire for depression and anxiety: Mini International Neuropsychiatric Interview Thai version 5.0.0 (M.I.N.I.5.0.0) module A,B,C,D
for major depressive disorder, and Thai Hospital Anxiety and Depression Scale (Thai HADS) for anxiety and depression.
Results : The prevalence of major depressive disorder among patients with Parkinson’s disease was found 0.72 %, dysthymia 2.2% and suicidality 14.4% all of which had low to moderate risk.
The present study could not find any statistical significant association between various factors and MDD in Parkinson’s disease. Thai HADS detected 2 patients (1.4 %) to have depressive state and 3 patients to have anxiety state (2.2 %).
Conclusion : The prevalence of major depressive disorder patients with Parkinson’s disease was very low. Suicidality was found only 14.4%, and no any significant risk factors were found
in association with MDD in Parkinson’s disease due to small sample size.
How to Cite
Aphisitphinyo, S., Arunpongpaisal, S., Tiamkoa, S., & Paholpak, P. (1). Prevalence of Major Depressive Disorder in Parkinson’s Disease at Srinagarind Hospital. Journal of the Psychiatric Association of Thailand, 62(2), 167-176. Retrieved from https://www.tci-thaijo.org/index.php/JPAT/article/view/92335
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.